About this item
Product details
Glinext MR (Modified Release) is a prescription oral anti-diabetic medicine containing Gliclazide 30 mg, a second-generation sulfonylurea. It is used to lower blood glucose levels in adults with type 2 diabetes mellitus when diet, physical exercise, and weight loss alone are insufficient to control blood sugar. The modified‑release formulation releases the active ingredient gradually over 24 hours, providing once‑daily blood sugar control that aligns with the natural circadian glucose profile. Gliclazide works by stimulating insulin secretion from the pancreatic beta‑cells and by improving the body’s sensitivity to its own insulin, helping to lower blood glucose levels and reduce the risk of long‑term diabetic complications Lowers Blood Sugar – Stimulates insulin production from the pancreas for better glucose control Improves Insulin Response – Enhances the body’s natural insulin function and reduces insulin resistance Helps Prevent Diabetes Complications – Supports the reduction of nerve damage, kidney issues, and cardiovascular problems associated with uncontrolled diabetes Composition Each modified released tablet contains: Gliclazide: 30 mg Directions for Use Use as directed by the physician
- Medicines
- 30 Modified Released Tablets
- 1 variant
- Protected Dastak checkout
Know before you buy
Specifications
- Department
- Health
- Subcategory
- Medicines
- Brand
- Next Pharma
- SKU
- 08961102450679
- Variant
- 30 Modified Released Tablets
- Tags
- Gliclazide, Medicine, Type 2 Diabetes
- Condition
- New
Customer feedback
Ratings & reviews
For help with a purchase, open your orders or contact Dastak support.
